XGN - Exagen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5241.42M
Enterprise Value 3189.45M
Trailing P/E N/A
Forward P/E 1-12.99
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)6.06
Price/Book (mrq)4.12
Enterprise Value/Revenue 34.76
Enterprise Value/EBITDA 6-31.80

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 321.38%
52 Week High 329.86
52 Week Low 311.54
50-Day Moving Average 322.29
200-Day Moving Average 319.01

Share Statistics

Avg Vol (3 month) 386.73k
Avg Vol (10 day) 364.05k
Shares Outstanding 512.56M
Float 3.68M
% Held by Insiders 134.50%
% Held by Institutions 156.14%
Shares Short (Jan 30, 2020) 478.25k
Short Ratio (Jan 30, 2020) 40.87
Short % of Float (Jan 30, 2020) 42.66%
Short % of Shares Outstanding (Jan 30, 2020) 40.62%
Shares Short (prior month Dec 30, 2019) 4144.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -24.98%
Operating Margin (ttm)-16.56%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)39.81M
Revenue Per Share (ttm)92.69
Quarterly Revenue Growth (yoy)26.90%
Gross Profit (ttm)17.06M
EBITDA -5.96M
Net Income Avi to Common (ttm)-31.04M
Diluted EPS (ttm)-72.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)77.83M
Total Cash Per Share (mrq)6.2
Total Debt (mrq)25.86M
Total Debt/Equity (mrq)44.08
Current Ratio (mrq)11.19
Book Value Per Share (mrq)4.67

Cash Flow Statement

Operating Cash Flow (ttm)-7.65M
Levered Free Cash Flow (ttm)N/A